In House Triplex Molecular Beacon (MB) Real-time PCR Assay for Detection of Mutations Associated with Rifampicin and Isoniazid-Resistant Mycobacterium tuberculosis
- سال انتشار: 1398
- محل انتشار: دومین کنگره سالیانه کشوری دانشجویی طبری و بیست و دومین کنگره سالیانه کمیته تحقیقات دانشجویی دانشگاه علوم پزشکی مازندران
- کد COI اختصاصی: SRMMED22_186
- زبان مقاله: انگلیسی
- تعداد مشاهده: 433
نویسندگان
Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
Background and Objective: The emergence of Mycobacterium tuberculosis strains resistant to the two most effective first-line drugs, isoniazid and rifampicin, demands for development of a rapid and sensitive detection method for the effective treatment and to prevent dissemination of resistant strains. In the present study, using molecular beacon(MB) we developed a multiplex real-time PCR assay for simultaneous and rapid detection of M. tuberculosis strains susceptible or resistance to the two most effective first-line drugs, isoniazid and rifampicin in a single tube. Methods: Three pairs of primers and MB probes targeting katG codon 315, rpoB 81-bp codons 526 and 531 and inhA promoter region of M. tuberculosis strain H37Rv genome were used and validated by a panel of 60 clinical isolates harboring bacilli susceptible and resistant to isoniazid and/or rifampicin. For specificity testing, DNA extracted from bacterial species other than M. tuberculosis, including M. africanum, M. microti, M. canetti, M. kansassii were amplified by the same sets of primers and the probes. Results: The limit detection of the MB assay was as low as 50 DNA copies/reaction mixtures. Little or no fluorescent signals were observed when amplification was performed using DNA extracted from other Mycobacterium species. Compared to drug susceptibility test (DST) results, for rifampicin resistance, the sensitivity of the assay was 91.6% and the specificity was 100%. For isoniazid resistance, overall the sensitivity was 87.5% and the specificity was 100%. Conclusion: Overall, single-tube real-time PCR assay with molecular beacon is able to rapidly detect M. tuberculosis strains susceptible or resistant to rifampicin and isoniazid antibiotics. However, the mutants which did not have genetic alterations in the target gene sequences were not detected. Therefore, including of other genetic targets would improve the sensitivity.کلیدواژه ها
Isoniazid, Molecular Beacon, Mycobacterium tuberculosis, Real-Time Polymerase Chain Reaction, Rifampicin.مقالات مرتبط جدید
- Evaluation of Candida auris Colonization using Clinical Skin Swabs: A Single-Center Study in Isfahan, Iran
- Support and Practice of Smoke-Free Eating Places in Sarawak, Malaysia: A Structural Path Analysis
- Rate and Causes of Claim Denials in Iranian Hospitals: A Systematic Review and Meta-analysis
- The Effect of Impulsivity on Addition and Addictive Tendencies: A Meta-analysis
- Prevalence of Nosocomial Infections During the COVID-۱۹ Pandemic: A Systematic Review and Meta-analysis
اطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.